Progressives push House chairmen to go bolder on drug pricing

Progressives push House chairmen to go bolder on drug pricing
© Greg Nash

Progressive House Democrats pushed two powerful committee chairmen on Tuesday to go bolder on legislation aimed at lowering drug prices.

During a meeting, the Congressional Progressive Caucus urged House Energy and Commerce Committee Chairman Frank Pallone Jr.Frank Joseph PalloneHouse reaches deal on continuing resolution, vote expected Thursday Democrats hold first hearing in push for clean energy by 2050 EXCLUSIVE: Swing-state voters oppose 'surprise' medical bill legislation, Trump pollster warns MORE (D-N.J.) and House Ways and Means Committee Chairman Richard NealRichard Edmund NealLobbying groups ask Congress for help on Trump tariffs Senate confirms two Treasury nominees over Democratic objections Trump urges judge to deny New York's motion to dismiss state tax return lawsuit MORE (D-Mass.) to support a far-reaching drug pricing bill that would allow the government to strip drug companies of their monopolies if they refuse to sell drugs at a reasonable price.

The progressives also pushed back on a competing proposal under discussion that would allow an outside arbiter to help set drug prices, warning that the idea would be too weak.

ADVERTISEMENT

The meeting comes as House Democrats try to bridge a divide that has opened up within the party on the best way to move forward on lowering drug prices, one of their signature issues.

Lawmakers said the chairmen listened during the meeting and expressed openness to different ideas while not offering a plan of their own.

Speaker Nancy PelosiNancy PelosiPatagonia says to shut stores for a few hours during Global Climate Strike Overnight Health Care — Presented by Partnership for America's Health Care Future — Pelosi unveils signature plan to lower drug prices | Trump says it's 'great to see' plan | Progressives pushing for changes Progressives push for changes to Pelosi drug pricing plan MORE's (D-Calif.) office is working on a drug-pricing proposal that would use arbitration, though lawmakers leaving the meeting Tuesday did not mention the Democratic leader when criticizing the arbitration idea.

Progressive Caucus leaders said a bill using arbitration — instead of the stronger mechanism of stripping monopolies — could lose many of their votes.

"There are members in our caucus who, if it comes out to be a weak arbitration bill that doesn't include a comprehensive list of drugs, I would have a hard time seeing something like that personally, as well as many other members," Rep. Mark PocanMark William PocanDemocrats press Nadler to hold Lewandowski in contempt Omar says US should reconsider aid to Israel Trump crosses new line with Omar, Tlaib, Israel move MORE (D-Wis.), co-chair of the Progressive Caucus, said after the meeting.

Neal did not rule out the stronger bill that the progressives want, which is sponsored by Rep. Lloyd DoggettLloyd Alton DoggettProgressives push for changes to Pelosi drug pricing plan Pelosi woos progressives on prescription drug pricing plan House Democratic Caucus chairman announces support for 'Medicare for All' MORE (D-Texas), when leaving the meeting.

Asked about that bill, Neal said, "All of these will be parts of the conversation, yeah, and I think the conversation is going to continue."

Asked if he is wedded to the idea of using an outside arbiter to set drug prices, Neal simply said, "No."

Doggett said leaving the meeting that it was a positive discussion and said he appreciated that the chairmen were not ruling out ideas.

"I don't view arbitration as really negotiation, it is just a way of shifting responsibility to an unaccountable third party," Doggett said.